Results

Total Results: 326 records

Showing results for "prescribed".

221. Screening for Asymptomatic Bacteriuria in Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/8YfPLRoMwTeaDgxJdYnYbb
     September 24, 2019 - among infants of women who screened negative for asymptomatic bacteri- uria and presumably were not prescribed

222. Archived: Evidence Summary: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary10/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication
     March 15, 2009 - archived Evidence Summary Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication March 15, 2009 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the …

223. Archived: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
     September 09, 2014 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication September 09, 2014 Reco…

224. Archived: Evidence Summary: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary10/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
     March 15, 2009 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication March 15, 2009 Recommendations made by the USPSTF are independent of t…

225. Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/t6yV6ZMHngeWgmTsoMMefM
     March 01, 2009 - Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence for the U.S. Preventive Services Task Force Tracy Wolff, MD, MPH; Therese Miller, DrPH; and Stephen Ko, MD, MPH Background: Coronary heart dise…

226. Archived: Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-diet-and-physical-activity-counseling-adults-with-high-risk-of-cvd-august-2014
     August 26, 2014 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counse…

227. Archived: Final Recommendation Statement: Screening for Depression in Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/depression-in-adults-screening
     January 26, 2016 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Screening for Depression in Adults January 26, 2016 Recommendations made by the USPSTF are independent of the U.S. government. They sh…

228. Ninth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/uspstf-annual-report-to-congress-2019.pdf
     January 01, 2019 - Ninth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services NOVEMBER 2019 High-Priority Evidence Gaps for Clinical Preventive Services SUBMITTED BY: Dr. Douglas K. Owens, Chair Dr. Karina W. Davidson, Vice Chair Dr. Alex H. Krist, Vice Chair ON BEHALF OF THE U.S. PREVENT…

229. Recommendation: Oral Health in Children and Adolescents Aged 5 to 17 Years: Screening and Preventive Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/oral-health-children-adolescents-screening-preventive-interventions
     November 07, 2023 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Oral Health in Children and Adolescents Aged 5 to 17 Years: Screening and Preventive Interventions November 07, 2023 Recommendations made by t…

230. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(9).pdf
     November 01, 2014 - High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress HIGH-PRIORITY EVIDENCE GAPS FOR CLINICAL PREVENTIVE SERVICES Fourth Annual REPORT TO CONGRESS November 2014 SUBMITTED BY: Dr. Michael LeFevre, Chair Dr. Kirsten Bibbins-Domingo, Vice Chair Dr. Albert Siu, Vice Chair ON …

231. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(6).pdf
     November 01, 2014 - High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress HIGH-PRIORITY EVIDENCE GAPS FOR CLINICAL PREVENTIVE SERVICES Fourth Annual REPORT TO CONGRESS November 2014 SUBMITTED BY: Dr. Michael LeFevre, Chair Dr. Kirsten Bibbins-Domingo, Vice Chair Dr. Albert Siu, Vice Chair ON …

232. Recommendation: Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions
     January 19, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions January 19, 2021 Recommendations made by the USPSTF are indepe…

233. Archived: Postmenopausal Hormone Replacement Therapy for Primary Prevention of Chronic Conditions: Evidence Summary: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/postmenopausal-hormone-replacement-therapy-for-primary-preve/v2-menopausal-hormone-therapy-preventive-medicatio
     August 21, 2002 - of menopause and to prevent chronic conditions such as osteoporosis. t is one of the most commonly prescribed

234. Archived: Postmenopausal Hormone Replacement Therapy for Primary Prevention of Chronic Conditions: Evidence Summary: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/postmenopausal-hormone-replacement-therapy-for-primary-preve/menopausal-hormone-therapy-preventive-medication-2002-2005
     August 21, 2002 - of menopause and to prevent chronic conditions such as osteoporosis. t is one of the most commonly prescribed

235. Postmenopausal Hormone Replacement Therapy for the Primary Prevention of Chronic Conditions: A Summary of the Evidence for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/sQ7hREGwnBm8Wh-LEFWP4F
     October 01, 2002 - It is one of the most commonly prescribed drugs in the United States.

236. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/JcwfLrEqaaxP6DPEQvxgUs
     February 18, 2020 - to “which population should be prescribed statin therapy?”

237. Recommendation: Gestational Diabetes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/gestational-diabetes-screening
     August 10, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Gestational Diabetes: Screening August 10, 2021 Recommendations made by the USPSTF are independent of the U.S. government. They should not b…

238. Evidence Summary: Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/peripheral-artery-disease-in-adults-screening-with-the-ankle-brachial-index
     July 10, 2018 - smoking cessation, and a low-fat diet, as well as cholesterol testing with aspirin and statin therapy prescribed

239. Evidence Summary: Adolescent Idiopathic Scoliosis: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/adolescent-idiopathic-scoliosis-screening
     January 09, 2018 - and on the anticipated tolerance of the patient. 5 Full-time rigid bracing: Most rigid braces are prescribed

240. Archived: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication
     March 15, 2009 - archived Final Recommendation Statement Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication March 15, 2009 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research a…